SEC Filing Analysis: BIO-RAD LABORATORIES, INC. (BIO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An insider-affiliated entity has filed a notice of proposed sale for a nominal amount of stock, representing an insignificant portion of the company's market capitalization and public float.
• Market Impact: The transaction is too small to have any meaningful impact on the stock price or trading volume.

Company Information

Field	Value
Company	BIO-RAD LABORATORIES, INC.
Ticker Symbol	BIO
CIK	0000012208
Industry	Laboratory Analytical Instruments

Insider Information

Field	Value
Name	Alles Institute for Medical Research Corp
CIK	0001957225
Title/Position	Not Applicable
Relationship	Director, 10% Stockholder (via affiliation with Alice Schwartz)

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-18 (Approximate)
Transaction Code	S (Proposed Sale)
Security Type	Common- Class A
Shares Involved	760
Price Per Share	~$301.04
Total Value	$228,793.04
Shares Owned After	Not Disclosed
Ownership Type	Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$228,793.04
% of Market Cap	0.0027%
Shares Transacted	760
% of Shares Outstanding	0.0035%
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with an $8.45 billion market capitalization, this transaction of approximately $229k is negligible.
• Transaction Significance: The sale represents a tiny fraction of both the market cap (<0.1%) and shares outstanding (<0.1%), placing it well below the threshold for even moderate significance. It is considered a routine, non-material event.

Additional Context

Transaction Notes

• Filing Type: Form 144 is a notice of proposed sale, not a confirmation of a completed sale.
• Origin of Shares: The shares were originally acquired by the filer as a donation from Alice Schwartz, who is a director and 10% shareholder of Bio-Rad Laboratories.